Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA crosslinking induced by platinum compounds represents a critical mechanism underlying their antitumor effects. By forming stable intra-, inter-strand, and protein-linked adducts within genomic material—primarily via bifunctional coordination chemistry—these agents disrupt vital cellular functions leading ultimately to cancer cell death. Their effectiveness depends not only on their ability to create diverse types of lesions but also on how cells recognize and attempt repair through complex molecular pathways involving multiple nuclear proteins[1][2][3].
Bifunctional binding via N7 guanine positions; forms intra/inter/protein links
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Crosslinking by Platinum Compounds.